From January 24 – 27, Dubai will host two of the most important healthcare trade shows of the entire region with Arab Health and Medlab Middle East being co-located at Dubai World Trade Center. Siemens Healthineers will display and demonstrate their latest products and solutions to visitors, both onsite and virtually in a hybrid exhibition approach, allowing them to reconnect with visitors at the venue, as well as virtually with the audience not able to attend in person.
Ole Per Maloy, Managing Director, Siemens Healthineers Middle East and Southern & Eastern Africa, said: “The entire team and I look forward to meeting our valued customers, business partners and visitors on our booths to guide them through the latest upgrades of our portfolio. We will also have our colleagues from Varian joining us on the show floor, to discuss news and updates in oncology and cancer treatment. According to our corporate purpose and New Ambition “We pioneer breakthroughs in healthcare. For everyone. Everywhere.” We want to use our innovation potential to transform the way healthcare works and provide access to high quality healthcare where it does not exist yet. To achieve this, we offer more flexible and tailored imaging solutions, smart remote services and optimized, AI driven workflow automations, decreasing diagnosis time and costs.”
At the Siemens stand at Arab Health 2022 in Sheikh Saeed Hall 1, Booth S1.D10, the focus will be on the latest innovations and solutions transforming healthcare in Medical Imaging, AI and Robotics.
For example, visitors will get to examine the MAGNETOM Free.Max MR scanner, the world's first 80cm wide-bore system, which improves patient experience by aiding MR scanning for obese and claustrophobic people. The SOMATOM suite of products on show include the patient-friendly ultra-low dose Computed Tomography scanners SOMATOM X.cite and SOMATOM X.ceed models offering the highest levels of patient comfort. On the show floor, the audience will be able to have a closer look at Siemens Healthineers’ Ultrasound ACUSON, all of which address current industry challenges by reducing repeat scans and sonographer injuries while improving diagnostic confidence.
Siemens Healthineers will also provide visitors with a detailed look into AI-powered augmented workflow solution, AI-Rad Companion. This cloud-based solution helps to not only reduce the burden of basic repetitive tasks and high case volumes, but increase diagnostic precision when interpreting medical images as well. In addition, representatives from Varian will share with visitors their vision of a world without fear of cancer and how intelligent cancer care will shape the future of oncology.
There will also be a demonstration on how Robotic technology is transforming healthcare with the Corindus CorPath GRX Robotic PCI system, and show how interventional cardiology physicians use joysticks and touchscreen controls to translate their hand movements into device control.
Medlab Middle East 2022 is going to be the largest edition so far in terms of exhibitor numbers and exhibition space and a milestone for the future of laboratory diagnostics and point-of-care solutions in the region, especially in the light of the ongoing pandemic and the lessons learnt for the industry. The focus for Siemens Healthineers at booth Z4.E10 will be on key components to enhance flexibility, automation and to redefine standardization across laboratories of all sizes. Driven by the company’s New Ambition, visitors will be provided with mutliple product launches for the region.
The latest addition to Siemens Healthineers’ Atellica® Hematology Portfolio pairs automation, intelligence, and extended parameters to streamline operations and support accurate clinical decision-making. Their global experts will demonstrate how to advance multidisciplinary workflows in labs with limited space with the Atellica® Task Targeted Automation system.
With Atellica® Integrated Automation (AIA), visitors will experience a consolidated, revolutionary sample management technology, intelligent software, and IT to provide workflow efficiency with the flexibility to add decapping with little or no additional footprint.
For their Point-of-Care portfolio, the focus will not only be on the latest IT solutions, but also on innovations in the palm of your hand. Flexible analzyers as handheld devices like the EPOC® NEXS Blood Analysis System are going to be launched and demonstrated at the booth, as well as the diabetes analyser Atellica® DCA, proving performance and precision needed to improve outcomes. Also presented to the audience will be the Atellica® VTLi Patient-side Immunoassay Analyzer, providing high-sensitivity troponin testing at the point of care with accurate results in just 8 minutes.
Follow the press team on Twitter: https://twitter.com/siemenshealthpr
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at http://www.siemens-healthineers.com.
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
